FDA/Industry Meeting Record Modifications May Be Requested By Sponsor
This article was originally published in The Tan Sheet
Executive Summary
Companies are encouraged to suggest modifications to documentation of FDA/industry meetings, FDA Deputy Director for Review Management Murray Lumpkin, MD, told a meeting sponsored by the Tufts Center for the Study of Drug Development in Philadelphia Jan. 27.